Azelaic acid foam 15%

DRUG3 trials

Sponsors

LEO Pharma, Clinical Research Center of the Carolinas, Sun Pharmaceutical Industries, Inc.

Conditions

Papulopustular RosaceaRosaceaRosacea, Papulopustular

Phase 1

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

CompletedNCT03689010

Sun Pharmaceutical Industries, Inc.Rosacea

Start: 2017-12-12End: 2018-09-28Updated: 2019-03-19

Phase 2

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

CompletedNCT01025635

LEO PharmaPapulopustular Rosacea

Start: 2009-12-31End: 2010-08-31Updated: 2020-03-31

Phase 4

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

CompletedNCT03418610

Clinical Research Center of the CarolinasRosacea, Papulopustular

Start: 2017-12-06End: 2019-01-09Updated: 2019-07-24